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IL-7 is essential for the development and homeostasis of T and B lymphocytes and is critical for neonatal lymph node 
organogenesis because Il7−/− mice lack normal lymph nodes. Whether IL-7 is a continued requirement for normal lymph 
node structure and function is unknown. To address this, we ablated IL-7 function in normal adult hosts. Either inducible 
Il7 gene deletion or IL-7R blockade in adults resulted in a rapid loss of lymph node cellularity and a corresponding defect in 
lymphocyte entry into lymph nodes. Although stromal and dendritic cell components of lymph nodes were present in normal 
numbers and representation, innate lymphoid cell (ILC) subpopulations were substantially decreased after IL-7 ablation. 
Testing lymphocyte homing in bone marrow chimeras reconstituted with Rorc−/− bone marrow confirmed that ILC3s in lymph 
nodes are required for normal lymphocyte homing. Collectively, our data suggest that maintenance of intact lymph nodes 
relies on IL-7–dependent maintenance of ILC3 cells.
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Introduction
The cytokine IL-7 is critical for the development of the lymphoid 
system. It has an obligate role in supporting development of B cell 
progenitors in the bone marrow (von Freeden-Jeffry et al., 1995). 
Similarly, in the thymus, survival and differentiation of early αβ 
T lineage precursors are dependent on IL-7 as is the specification 
of the γδ T cells (von Freeden-Jeffry et al., 1995; Ye et al., 2001). In 
addition to supporting lymphocyte development, IL-7 also plays a 
key role in promoting the normal development of lymph nodes in 
neonatal mice (Coles et al., 2006). Organogenesis of lymph nodes 
is orchestrated by interactions between stromal and endothelial 
lymphoid tissue organizer (LTo) cells (Cupedo et al., 2004; Onder 
et al., 2013) and hematopoietic lymphoid tissue inducer (LTi) 
cells, which are now identified as a RORγt-expressing member 
of the innate lymphoid cell family (ILC3; Sun et al., 2000; Eberl et 
al., 2004). Although maturation of LTo cells is dependent on lym-
photoxin (LT) signaling, ILC3s in developing lymph nodes rely on 
IL-7 for development and proliferation, and IL-7–deficient mice 
have severely reduced numbers of all ILC3 populations (Satoh-
Takayama et al., 2010) and consequently exhibit defective lymph 
node development (Coles et al., 2006).
In fully mature lymph nodes, these cellular components per-
sist and continue to play important functions in lymph node 
homeostasis and immune function. Stromal cell components, 
such as fibroblastic reticular cells (FRCs), secrete T cell trophic 
chemokines CCL19 and 21 and therefore play critical roles in driv-
ing cellular localization within nodes (von Andrian and Mempel, 
2003). There is also a continued requirement for LT signaling. 
In mature nodes, LT produced by dendritic cells (DCs) regulates 
functionality of high endothelial venule (HEVs; Moussion and 
Girard, 2011; Wendland et al., 2011), promoting expression of 
L-selectin ligands and therefore migration of lymphocytes into 
lymph nodes (Browning et al., 2005). IL-7 is produced within 
lymph nodes by both FRCs (Link et al., 2007) and lymphatic 
endothelial cells (LECs; Onder et al., 2012) and is critical for long-
term survival of all major αβ T cell subsets (Schluns et al., 2000; 
Seddon and Zamoyska, 2002). Although it is clear IL-7 signaling 
plays a critical role in developing fully mature lymph node struc-
tures, it is unknown whether IL-7 continues to have a function in 
maintaining normal lymph node integrity beyond its influence 
on mature T cell survival.
In the present study, we investigated whether continued IL-7 
expression was required for the maintenance of fully developed, 
adult lymph nodes. We tested this both by ablating IL-7 expres-
sion genetically and inhibiting IL-7 signaling by receptor block-
ade. Our study reveals a critical role for IL-7 in the maintenance 
of lymph node size in adults and as a requirement for T and B 
cell entry and provides evidence of a mechanism dependent not 
on LT signaling but rather on maintenance of ILC3 populations.
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Results and discussion
Generation of mice with conditional Il7 loci
To facilitate the study of  IL-7 in adult mice, we generated a 
strain with a modified Il7 allele that permits conditional 
gene ablation by using the Cre-Lox system (see Materials and 
methods). In brief, embryonic stem (ES) cells with the tar-
geted Il7tm1a(EUC OMM)Wtsi locus were obtained from the Euro-
pean Conditional Mouse Mutagenesis Program consortium. 
Targeting resulted in FRT-site–flanked LacZ and neomy-
cin resistance (Neo) cassettes upstream of exon 3 and LoxP 
recombination sites both flanking the neomycin cassette and 
downstream of exon 4 (Fig. S1 A). To test the functionality 
of the modified allele, Il7tm1a(EUC OMM)Wtsi mice were bred with 
PC3-Cre mice to induce germline deletion of the LoxP-flanked 
Neo cassette and exons 3 and 4 of  the Il7 gene but leaving LacZ 
gene expression intact and under control of  endogenous Il7 
regulatory elements (Il7LacZKO allele; Fig. S1 A). LacZ and Neo 
cassettes were removed by breeding Il7tm1a(EUC OMM)Wtsi mice 
with actin-FlpE recombinase mice, which resulted in off-
spring in which exons 3 and 4 of Il7 were flanked by LoxP sites 
(Il7flox allele; Fig. S1 A). Analysis of  lymphoid compartments 
of  mice homozygous for the Il7LacZKO allele revealed a pheno-
type consistent with existing Il7 knockouts (von Freeden-
Jeffry et al., 1995). Mice were lymphopenic, with reduced 
numbers of  peripheral T and B cells in the lymph nodes and 
spleen (Fig. S1, B and C). Thymi were also small and exhibited 
an expected developmental block at the DN2 stage (Fig. S1 D). 
Together, these data confirmed the successful generation of  a 
conditional Il7 allele.
Conditional deletion of Il7 gene in adult mice results in loss of 
T cell numbers and reduced lymph node sizes
To permit ablation of Il7 gene expression in adults, Il7flox strain 
was bred with Rosa26CreERT2 (R26CreERT) mice, which ubiquitously 
express a tamoxifen hormone–inducible Cre. Tamoxifen was 
administered daily for 5 d to either Il7flox/LacZKO R26CreERT mice or 
Cre –ve littermates as control. Il7 mRNA levels were measured 
in RNA extracted from whole-organ homogenates of the lymph 
nodes and spleen 3 wk after the first tamoxifen administration. 
This revealed a substantial reduction in the abundance of Il7 
mRNA in both the lymph node and spleen of Il7flox/LacZKO R26CreERT 
mice (Fig. 1 A). Basal levels of Il7 mRNA were far higher in lymph 
nodes than in the spleen, consistent with studies of IL-7 reporter 
mouse strains (Kim et al., 2011).
In the absence of IL-7 signaling, T cells have a half-life of 
approximately 4 wk (Seddon and Zamoyska, 2002; Buentke et 
al., 2006). Consistent with this, after IL-7 gene deletion, anal-
ysis of total numbers of naive CD4 and CD8 T cells revealed 
more than a twofold reduction 4 wk after tamoxifen treatment 
(Fig. 1 B). However, analysis of different lymphoid subcompart-
ments revealed an unequal distribution of naive cells. Unex-
pectedly, we observed a far greater and more rapid reduction 
of naive T cells in the lymph nodes than in the spleen by 2 wk 
(Fig. 1 B). It also appeared that total cellularity of lymph nodes 
was already far smaller at 2 wk than could be accounted for sim-
ply by the reduction in total T cell numbers (Fig. 1 C).
T and B cell entry into lymph nodes is impaired 
after IL-7 deletion
The uneven distribution of naive T cells between the lymph 
nodes and the spleen suggested that the rapid reduction in lymph 
node size after ablation of IL-7 expression was not simply a con-
sequence of changes to mature T and B cell compartment sizes. 
Figure 1. Loss of naive T cells and lymph node size after ablation of IL-7 
expression. (A) Groups of Il7fx/KO R26CreERT2 mice (n = 3, closed bars) were 
treated with tamoxifen for 5 d, and CreERT –ve littermates (n = 3, open 
bars) were also treated as controls. 3 wk later, total mRNA was isolated 
from whole-organ homogenates of mesenteric, peripheral lymph nodes and 
spleen, and Il7 gene expression determined by real-time PCR. mRNA levels 
were normalized against Hprt. Bar charts show the relative abundance of Il7 
mRNA from different organs of the indicated donor mice. (B) Cohorts of Il7fx/KO 
R26CreERT2 mice and CreERT –ve littermate controls were treated with tamox-
ifen for 5 d. Lymph nodes and the spleen were taken from groups of mice 
(n = 3 per group) 2 and 4 wk after treatment and analyzed by FACS. Graphs 
show total numbers of TCRhi CD44lo CD25– naive CD4 and TCRhi CD44lo naive 
CD8 T cells recovered from the indicated organs from Il7fx/KO R26CreERT2 mice 
(closed symbols) vs. CreERT –ve littermate controls (open symbols). (C) Plots 
show total cell numbers recovered from the lymph nodes and spleen of the 
mice described in B. Data are representative of three or more independent 
experiments. Error bars show SEM.
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It might instead reflect specific changes in lymph node homeo-
stasis, such as lymphocyte entry via HEVs that are not present 
in spleen. To test this, we assessed the capacity of T cells from 
normal donors to home to lymph nodes of IL-7–deficient hosts 
in short-term migration experiments. Because donor cells were 
from unmanipulated mice, we could exclude any potential com-
pounding effects of IL-7 deprivation on host T cell function. Total 
lymphocytes from CD45.1 donors were injected into R26CreERT+ 
and R26CreERT– Il7flox/LacZKO hosts, 2–3 wk after their treatment 
with tamoxifen. Abundance of donor cells in the blood, spleen, 
and lymph nodes was assessed 1 h later. Frequencies of donor 
lymphocytes in the blood of different host mice was similar 
(Fig. 2 A), although there was a nonsignificant trend to greater 
numbers of donor cells in the spleen of R26CreERT+ Il7flox/LacZKO 
hosts (Fig. 2 B). In contrast, both donor T and B cells were greatly 
reduced in numbers in lymph nodes from R26CreERT+ Il7flox/LacZKO 
hosts compared with littermate R26CreERT– Il7flox/LacZKO hosts 
(Fig. 2 C). These data revealed defective entry of lymphocytes 
into lymph nodes of hosts lacking IL-7 expression.
Normal stromal and DCs but reduced ILCs in the absence of IL-7
To investigate the mechanism by which IL-7 was regulating 
lymph node size, we asked whether key components of lymph 
node structure and function were affected by loss of IL-7 expres-
sion. FRCs and LECs are important structural components of 
lymph nodes and are also sources of IL-7 synthesis (Link et al., 
2007; Onder et al., 2012), whereas blood endothelial cells (BECs) 
include HEVs that are key points of entry to lymph nodes. We 
therefore analyzed the phenotype and composition of stromal 
cell subsets after IL-7 deletion. We used expression of gp38 and 
CD31 by CD45– cells to identify gp38+CD31– FRC and gp38+CD31+ 
LECs, as well as gp38–CD31+ BECs (Fig. 3 A). Importantly, despite 
the substantial reduction in lymph node size after IL-7 ablation, 
both numbers and representation of these stromal cell types were 
unaffected after the loss of IL-7 (Fig. 3 A). Entry of lymphocytes 
into lymph nodes via HEVs depends on lymphocyte adherence 
mediated by L-selectin and integrin binding and is stimulated by 
chemokines. Analyzing blood endothelia for expression of L-se-
lectin and integrin ligands, PNAd and ICAM-1, respectively, did 
not reveal any defects after IL-7 ablation (Fig. 3 B). Histological 
analysis of PNAd and CD31 revealed normal HEV structures in 
lymph nodes after IL-7 ablation (Fig. 3 C). A more global analysis 
of gene expression within lymph nodes did not reveal any dif-
ferences in expression of PNAd scaffolds and glycan synthetic 
enzymes required for appropriate glycosylation of scaffolds nor 
alterations in chemokine or LT expression (Fig. 3 D). DCs have 
also been implicated in regulating lymph node size both at steady 
state (Moussion and Girard, 2011; Wendland et al., 2011) and 
during immune responses (Acton et al., 2014). However, quanti-
fication of resident, migratory, and plasmacytoid DC populations 
revealed no detectable changes in numbers or composition after 
IL-7 deletion in either the lymph nodes or spleen (Fig. 3 E).
Finally, we analyzed the ILC composition of lymph nodes. ILC3 
are critical for initial development and maturation of lymph node 
anlagen during embryogenesis and neonatal lymphoid coloniza-
tion. Although their role in maintaining integrity and function 
of mature lymph nodes has not previously been assessed, it was 
possible they may continue to play a function after lymph nodes 
are fully developed. We therefore asked whether IL-7 ablation 
affected ILC numbers and/or representation in lymph nodes. In 
contrast to stromal and DC components, we did indeed observe 
substantial reductions in numbers of both ILC2 and ILC3 subsets 
in the lymph nodes and spleen after gene deletion (Fig. 3 F).
IL-7R blockade in T cell–deficient mice reduces ILC numbers 
and impairs lymphocyte entry into lymph nodes
Our results suggested that IL-7 is required for normal entry of 
lymphocytes into lymph nodes. To test whether this function of 
IL-7 was independent of its role in T and B lymphocyte homeo-
stasis, we tested the effects of IL-7 blockade on lymphocyte entry 
into lymph nodes in T cell–deficient Zap70−/− hosts and Rag1−/− 
hosts that lack both T and B cells. We blocked IL-7 activity using 
the anti–IL-7R mAb A7R34 that inhibits binding of cytokine 
to the IL-7Rα chain (Sudo et al., 1993). Groups of Zap70−/− and 
Rag1−/− hosts were treated with anti-IL-7R for 2 wk. Controls were 
injected with either PBS or isotype control antibody. Analyzing 
ex vivo binding of A7R34 confirmed blockade of >90% of IL-7R 
on ILCs in lymph nodes (Fig. 4 A). Mice treated with anti–IL-7R 
exhibited a reduction in lymph node size but not spleen size 
(Fig. 4 B), as observed after IL-7 gene deletion. We then assessed 
Figure 2. Short-term homing of T and B cells to lymph nodes is impaired 
after IL-7 gene ablation. Il7fx/KO R26CreERT2 mice and CreERT –ve littermate 
controls (n = 6 per group) were treated with tamoxifen for 5 d. 2–3 wk later, 
hosts were injected i.v. with 107 total lymph node cells from congenic CD45.1 
donors. 1 h later, mice were culled, and blood samples, lymph node cells, and 
splenocytes were analyzed by FACS. (A–C) Bar charts show the numbers of 
donor CD45.1+ CD4, CD8, and B lymphocytes in the blood (A), spleen (B), 
and lymph nodes (C) of R26CreERT2 –ve (Cre–) and R26CreERT2 +ve (Cre+) Il7fx/KO 
hosts at 1 h after transfer. Data are representative of three independent exper-
iments. *, P < 0.05; **, P < 0.01. Error bars show SEM. 
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Figure 3. Normal numbers of stromal and dendritic subsets but reduced ILC populations in lymph nodes after IL-7 ablation. Il7fx/KO R26CreERT2 mice (n = 4) and 
CreERT –ve littermate controls (n = 4) were treated with tamoxifen for 5 d. 3 wk later, lymph nodes were recovered and cell composition analyzed by FACS. (A) Density 
plots are of CD45 vs. SSc on total live cells and show CD45– gate used to display gp38 vs CD31 (PEC AM-1) density plots used to identify FRCs, LECs, and BECs. Bar chart 
shows total numbers of these subsets recovered from R26CreERT2 +ve (closed bars) and R26CreERT2 –ve Il7fx/KO mice (open bars). (B) Density plots are of Meca79 vs. anti-
ICAM-1 staining by CD31+gp38– BECs from representative mice described in A. Meca79 was either stained ex vivo in cell suspensions (Total Meca79) or by injection of mice 
with Meca79 mAb before ex vivo staining and analysis (luminal Meca79). Histograms are of ICAM-1 and Meca79 staining (total vs. luminal) by cells from Cre+ (solid line) 
or Cre– litter mates (gray shading), gated on Meca79+ICAM-1+ cells defined by the gate shown on density plots. (C) Frozen sections from lymph nodes from the indicated 
mice were analyzed for expression of PNAd (green), CD31 (red), and counterstained with nuclear DAPI staining. (D) Il7fx/KO R26CreERT2 mice (n = 3) and CreERT –ve littermate 
controls (n = 3) were treated with tamoxifen for 5 d. 3 wk later, total mRNA was isolated from total lymph nodes of individual mice and gene expression determined by 
RNAseq. Bar charts show mRNA expression level in transcripts per kilobase million (TPM) of the indicated genes. (E) Density plots are of CD11c vs. Class II MHC (MHC II) 
and PDCA-1 vs. CD11c, used to identify MHC II+CD11cHi resident DC (Res), MHC IIHi CD11c+ migratory DC (Mig), and PDCA-1+CD11c+ plasmacytoid DCs (pDC). Bar charts 
show total numbers of these DC subsets recovered from the lymph nodes and spleen of R26CreERT2 +ve and R26CreERT2 –ve Il7fx/KO mice. (F) Density plots are of IL-7R vs. 
Lin; histograms are of Thy1 expression by IL-7R+lin–-gated cells. Density plots are of Gata3 vs. RORgt expression by Thy1+ IL-7R+lin– ILCs. Histograms are of CD4 expression 
by RORgt+ ILCs. Bar charts show total numbers of ILC subsets isolated from the lymph nodes and spleen of R26CreERT2 +ve and R26CreERT2 –ve Il7fx/KO mice. Data are rep-
resentative of three independent experiments (A–D), a pool of two experiments (E), or four independent experiments (F). *, P < 0.05; **, P < 0.01. Error bars show SEM.
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entry of lymphocytes into lymph nodes of treated hosts in short-
term homing assays. Significantly, migration of both T and B 
cells into lymph nodes was reduced in anti–IL-7R–treated hosts 
(Fig. 4 C) but not migration into the spleen (Fig. 4 D). Analyzing 
lymph nodes of treated Zap70−/− and Rag1−/− mice revealed that 
ILC numbers were in both cases substantially reduced after block-
ade of IL-7R (Fig. 4 E). Therefore, the requirement for IL-7 for 
normal lymphocyte migration into lymph nodes did not depend 
on the prior presence of T or B lymphocytes within lymph nodes 
and correlated with the presence of ILC populations. Because 
IL-7Rα chain is also a component of the TSLP receptor, A7R34 
could also act by blocking TSLP signaling. Although lymphoid 
development is normal in Tslp−/− mice (Al-Shami et al., 2004), 
we do not exclude a nonredundant role for TSLP alongside IL-7 
in the lymphocyte homing phenotype.
ILC3s are required for normal migration of lymphocytes 
into lymph nodes
Our data reveal that IL-7 was constitutively required for normal 
migration of lymphocytes into lymph nodes and was indepen-
dent of the presence of T or B cells within nodes. Stromal and DC 
populations were seemingly unaffected by loss of IL-7. Our anal-
ysis did reveal a specific loss of ILCs within lymph nodes. Specific 
ablation of ILC2s has no impact on lymph node size or composi-
tion (Oliphant et al., 2014). We therefore hypothesized that ILC3s 
may be required for normal entry of lymphocytes into nodes and 
that the role of IL-7 in this function was to ensure homeostatic 
maintenance of these ILC populations within lymph nodes. To 
test this, we analyzed lymphocyte entry into lymph nodes of 
experimental mice specifically deficient in ILC3s. Rorc−/− mice 
lack ILC3 populations but consequently lack lymph node struc-
tures because of the developmental requirements for ILC3s. 
Therefore, we generated bone marrow chimeras in which lethally 
irradiated WT hosts were reconstituted with bone marrow from 
Rorc−/− donors and conditioned with anti-Thy1 mAb to help elim-
inate radioresistant ILCs. In these chimeras, donor bone marrow 
failed to reconstitute ILC3 populations, and the combination of 
irradiation and anti-Thy1 treatment resulted in a substantial 
reduction in host ILC3 populations (Fig. 5 A). Initial analysis of 
chimeras revealed a reduction in the total size of the lymph node 
compartment of WT chimeras reconstituted with donor Rorc−/− 
bone marrow (Fig. 5 B). Testing the ability of lymphocytes to enter 
lymph nodes revealed that entry of both T and B lymphocytes 
(Fig. 5 C) was profoundly impaired in chimeras reconstituted 
with Rorc−/− bone marrow. Histological analysis of lymph nodes 
from chimeras revealed grossly normal CD31+ HEV structures in 
which PNAd expression was readily detectable (Fig. 5 D). Finally, 
we asked whether homing defects induced after IL-7R blockade 
could be specifically rescued by ILC3s. To do this, we generated 
control and Rorc−/− chimeras using CD45.1 hosts that were con-
ditioned with anti–IL-7R treatment at the time of reconstitution. 
Blocking IL-7R in chimeras resulted in the expected defect in 
lymphocyte homing to lymph nodes by 2 wk after bone marrow 
transplant (BMT), compared with chimeras treated with isotype 
control mAb (Fig. 5 E). Analyzing ILC subsets in fully reconsti-
tuted chimeras revealed that anti–IL-7R–treated hosts given WT 
bone marrow were able to partially reconstitute ILC3s in lymph 
Figure 4. IL-7 blockade in vivo impairs lymphocyte entry into lymph 
nodes but not spleen. Cohorts of Zap70−/− and Rag1−/− hosts were i.p. 
injected three times per week for 2 wk with either A7R34 anti-IL-7R mAb 
or PBS as control. Hosts were then injected i.v. with 107 total lymph node 
cells from CD45.1 congenic donors. 1 h later, host the lymph nodes and 
spleen were analyzed by FACS. (A) Density plot is of Thy1 vs. Lin to indicate 
ILC gate. Histogram is of IL-7R expression by ILCs in PBS-treated (broken 
line) vs. A7R34-treated Zap70−/− hosts (solid line), compared with B cells 
in PBS-treated hosts (gray shading). Bar chart shows MFI of IL-7R by ILC 
and B cells in the indicated hosts. (B) Bar charts are of total cell numbers 
recovered from the lymph nodes or spleen of the indicated hosts treated 
with either anti-IL-7R mAb (αIL-7R, shaded bars) or PBS as control (white 
bars). (C and D) Stacked bar charts indicate the combined total of donor 
CD4 (dark gray) and CD8 (light gray) T cells recovered from the lymph 
nodes (C) or spleen (D) of Zap70−/− (left column) or Rag1−/− hosts (right 
column). Bar charts are of donor B cells recovered from the same hosts. 
(E) Bar charts show total host ILC subsets recovered from the lymph nodes 
of the indicated hosts treated with either anti-IL-7R mAb (αIL-7R, shaded 
bars) or PBS as control (white bars). Data are the pool of three (Zap70−/− 
hosts, n = 8 per group; Rag1−/− hosts, n = 11 per group) independent exper-
iments. In one replicate experiment, Zap70−/− hosts receiving 2A3 isotype 
control vs. A7R34 generated equivalent data to those using PBS control 
for A7R34. *, P < 0.05; **, P < 0.01. Error bars show SEM.
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nodes when compared with isotype control-treated chimeras, 
although recipients of Rorc−/− bone marrow reconstituted only 
ILC2 populations (Fig. 5, F and G). Importantly, assaying short-
term lymphocyte homing to lymph nodes in the different hosts 
revealed that lymphocyte homing was also partially rescued in 
anti–IL-7R–treated WT chimeras, compared with isotype-treated 
controls, and anti–IL-7R–treated Rorc−/− chimeras in which lym-
phocyte homing remained impaired (Fig. 5 H).
The role of IL-7 in the development of lymph node structures 
in neonates has long been recognized. Our new data reveal that 
IL-7 continues to play an important role in the normal function 
of lymph nodes in adulthood too, because ablation of IL-7 expres-
sion or activity resulted in impaired migration of T and B cells 
into lymph nodes. In neonates, IL-7 is required for development 
of LTi/ILC3s, and it appears that their maintenance in adults con-
tinues to be IL-7 dependent, and the persistence of ILC3s remains 
important for normal lymph node function. We did not find any 
obvious defects in the positive regulators of HEV function after 
IL-7 ablation. The key structures and cues required for the migra-
tion of T and B cells into lymph nodes appeared intact. However, 
there is also evidence that HEVs are maintained in a dynamic 
equilibrium that balances cellular exclusion and permeability to 
cells in the blood (Herzog et al., 2013), raising the possibility that 
ILC3s may counter forces of exclusion, rather than positively reg-
ulate mechanisms of entry. Identifying these mechanisms will be 
important subjects for future studies.
Our data also reveal another important function for IL-7 
production by stroma in promoting optimal immunity. There 
is good evidence that loss of IL-7 production by stroma under-
lies thymic atrophy suffered during aging. It seems likely that 
stromal components of other lymphoid tissues may suffer a 
similar loss of IL-7–producing capacity with age. Therefore, the 
effects on lymphocyte recirculation through lymph nodes in the 
absence of optimal IL-7 production may represent an additional 
consequence of aging, in addition to the anticipated effects on T 
cell development and maintenance, that together contribute to 
loss of immunity in old age. Our findings therefore identify an 
additional potential mechanism by which IL-7 therapy may help 
restore immune function as a consequence of age-related loss of 
endogenous cytokine.
Materials and methods
Mice
ES cells bearing the Il7tm1a(EUC OMM)Wtsi targeted mutation were 
purchased from the European Mouse Mutant Cell Repository and 
used to generate chimeric mice by standard blastocyst injection. 
Null (Il7LacZKO) and conditional (Il7flox) alleles of the Il7 gene were 
generated by intercrossing Il7tm1a(EUC OMM)Wtsi mice with PC3-Cre 
and actin-FlpE strains, respectively (Fig. S1 A). All mouse strains 
used in this study were bred in a conventional colony free of 
pathogens at the National Institute for Medical Research in Lon-
don and the Comparative Biology Unit, University College Lon-
don (UCL). Two experiments using Rorc−/− chimeras and controls 
were performed in the Department of Hematology, Erasmus Uni-
versity Medical Center, Rotterdam, Netherlands. All mice were 
on a C57BL/6J background (N5). 5 mg tamoxifen (T5648; Sigma) 
dissolved in corn oil (C8267; Sigma) was given daily to mice by 
oral gavage for 5 consecutive days. Groups of mice were treated 
with anti–IL-7R mAb (Clone A7R34; Bio X Cell), 0.3 mg/injection 
delivered i.p. three times per week. Controls received injections 
of PBS or isotype (Clone 2A3; Bio X Cell). Chimeras were gen-
erated by irradiating WT hosts with 9 Gy. WT hosts were then 
injected with 1–1.5 × 107 bone marrow cells from Rorc−/− or WT 
control donors. To eliminate residual radioresistant host ILC3s, 
2 wk after bone marrow reconstitution, chimeras received five 
i.p. injections of 200 µg α-Thy1 antibody over 2 wk (YTS154; pro-
vided by H. Waldmann; Aparicio-Domingo et al., 2015). Animal 
experiments were performed according to the UCL Animal Wel-
fare and Ethical Review Body and Home Office regulations.
Flow cytometry
Normally, thymus, spleen, and mesenteric and peripheral lymph 
nodes were meshed through a 70-µm nylon mesh, and the cell 
concentrations were determined with a Scharf Instruments 
Casy Counter. Inguinal, cervical, axillary, and brachial lymph 
nodes were dissected in individual mice. For the isolation of ILCs 
and DCs, individual lymph nodes were pierced with fine forceps 
and digested for 25 min at 37°C in RPMI with 0.42 mg/ml Liber-
ase TL (Roche) and 0.1 mg/ml DNase I (Roche). The reaction was 
stopped with 10  mM EDTA. Digested tissue was then crushed 
through a 70-µm nylon mesh. Stromal cells were isolated as 
previously described (Fletcher et al., 2011). For the detection of 
luminal PNAd, mice were injected i.v. with 50 µg biotin-conju-
gated MECA-79 (clone Meca79; Biolegend) and sacrificed after 
20 min. Cells were incubated with saturating concentrations of 
antibodies in 100 µl PBS containing BSA (0.1%) and 1 mM azide 
(PBS-BSA-azide) for 45 min at 4°C followed by two washes in 
PBS-BSA-azide. Antibodies raised against the following mouse 
antigens were used: CD3e (clone 145-2C11; eBioscience), CD4 
(clone RM4-5; eBioscience, Biolegend), CD5 (clone 53-7.3; Bio-
legend), CD8 (clone 53-6.7; Biolegend, BD), CD19 (clone 6D5; 
Biolegend), CD24 (clone M1/69; Biolegend), CD25 (clone PC61.5; 
eBioscience, Biolegend), CD31 (clone 390; eBioscience, Bioleg-
end), CD44 (clone IM7; eBioscience, BD), CD45.1 (clone A20; 
Biolegend), CD45.2 (Clone 104; eBioscience, Biolegend), CD122 
(clone 5H4; eBioscience), TCRβ (clone H57-597;eBioscience, Bio-
legend), TCRγδ (clone GL3; Biolegend), B220 (clone RA3-6B2; 
Biolegend), CD11b (clone M1/70; Biolegend), CD11c (clone N418; 
Biolegend), PDCA-1 (clone 129c1; Biolegend), MHC II (clone 
M5/114.15.2; eBioscience), gp38 (clone eBio8.1.1; eBioscience), 
Meca79 (clone Meca79; Biolegend), ICAM-1 (clone YN1/1.7.4; Bio-
legend), Thy1.2 (clone 30-H12; Biolegend), IL-7Rα (clone A7R34; 
eBioscience), F4/80 (cloneBM8; Biolegend), CD49b (clone DX5; 
Biolegend), GR1 (clone RB6-8C5; Biolegend), Ter-119 (clone 
Ter-119; Biolegend), NK1.1 (clone PK136; Biolegend), GATA3 
(clone L50-823; BD), RORγT (clone Q31-378; BD), and Strepta-
vidin BUV737 (BD). In the thymus, the lineage dump channel 
for CD4 CD8 double-negative populations contained antibod-
ies against GL3, CD19, GR1, CD11b, F4/80, NK1.1, and CD11c. In 
lymph nodes, the lineage stain for ILCs contained antibodies 
against CD3e, TCRβ, GL3, CD19, GR1, CD11b, and F4/80 except in 
Figs. 4 and 5 where additional Ter-119, NK1.1, CD49b, and CD11c 
were included. Cell viability was determined by using the LIVE/
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Figure 5. Lymphocyte entry into lymph nodes is defective in the absence of ILC3s. (A–D) Mice specifically lacking ILC3s were generated by reconstitution 
of irradiated WT hosts with bone marrow from Rorc−/− (n = 9) or WT (n = 10) donor bone marrow as control. Both groups were also treated with anti-Thy1 for 
2 wk after BMT. 12 wk after reconstitution, hosts were injected with 107 labeled WT lymphocytes from either the spleen or a mixture of the lymph nodes and 
spleen, and 1 or 3 h later cell numbers in the lymph nodes and spleen were determined by FACS. (A) Density plots are of IL-7R vs. Lin for total lymphocytes and 
Gata3 vs. RORgt by IL-7R+Lin−-gated cells. Bar charts show total numbers of ILC subpopulations in the indicated chimeras. (B) Bar charts are of total lymph 
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DEAD cell stain kit (Invitrogen Molecular Probes). Intracellular 
staining was performed by using the FoxP3 fixation and perme-
abilization kit (eBioscience). The addition of SPH ERO TM Accu-
Count fluorescent particles (Spherotech, Inc.) was used to cal-
culate cell frequencies. 8–13-color flow cytometric staining was 
analyzed on a FAC SCanto II or LSRFortessa X-20 (Becton Dick-
inson) instrument, and data analysis and color compensations 
were performed with FlowJo V9.5.3 software (TreeStar). Data are 
displayed on log and biexponential displays.
Short-term migration assay
107 lymphocytes from lymph nodes, and in indicated experi-
ments also the spleen, were injected i.v. into groups of experi-
mental mice. 1 h later, lymph node, spleen, and blood samples 
were recovered and analyzed by FACS. Numbers of donor cells 
present in different organs were determined on the basis of 
either prior CTV labeling (0.5 µM; Thermo Fisher Scientific) or 
expression of congenic CD45.1 by adding counting beads to sam-
ples and analyzing cells by flow cytometry.
RNA sequencing and real-time quantitative PCR
Tissue samples were homogenized in 600 μl RLT lysis buffer 
(Qiagen) by using a Precellys Homogenizer, and RNA was iso-
lated by using the RNeasy Mini kit (Qiagen) according to the 
manufacturer’s instructions. RNA integrity was confirmed 
by using Agilent’s 2100 Bioanalyzer. mRNA libraries were 
prepared by using the KAPA mRNA Hyper Prep kit (Roche), 
following manufacturer’s instructions. 75-bp single-end 
reads were generated by using an Illumina HiSeq 2500. The 
raw Illumina reads were analyzed as follows: Read trimming 
and adapter removal were performed by using Trimmomatic 
(version 0.36). The RSEM package (version 1.2.31) together 
with STAR (version 2.5.2a) were used to align reads to the 
mouse genome (ensembl GRCm38 release 86) and to obtain 
gene level counts. Differential expression analysis was per-
formed by using DESeq2 package (version 1.14.1) within R 
version 3.3.2. Data are deposited in ArrayExpress, acces-
sion no. E-MTAB-6451. For real-time PCR, cDNA was pro-
duced by reverse transcription, and levels of Il7 mRNA (FAM 
probeMm01295803_m1; AppliedBiosystems) were deter-
mined using Applied Biosystems ABI Prism 7900 sequence 
detection system. Il7 mRNA levels were normalized against 
Hprt1 mRNA (FAM probe Mm00446968_m1). 
Immunohistochemistry
6-μm cryosections were fixed for 5 min in ice-cold acetone and 
air-dried for an additional 10 min. After blocking of Fc receptors 
with serum, sections were incubated with primary antibodies for 
1 h at room temperature, followed by a 30-min incubation with 
aFluor-Alexa-labeled conjugate (Molecular Probes). Sections 
were embedded in ProLong Gold (Invitrogen) and analyzed on a 
Leica DMR XA fluorescent microscope. The antibodies used were 
CD31 (clone 390; eBioscience), PNAd (Meca79; supernatant was 
provided by R. Mebius, VU University Medical Center Amster-
dam, Amsterdam, Netherlands).
Statistics
Statistical analysis and figure preparation were performed by 
using Graphpad Prism 6 (v6.0a). Column data were compared by 
nonparametric unpaired two-tailed Mann–Whitney test. *, P < 
0.05; **, P < 0.01.
Online supplemental material
Fig. S1 shows the phenotype of Il7LacZKO mice.
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